Abstract:Acute ischemic stroke is a major factor cause of severe morbidity and mortality in general population. Newer modality of treatment like IV thrombolysis has been established to prevent long term complications in this condition within 4.5 hours of symptoms onset. The data regarding IV thrombolysis is limited in rural areas. Various factors like lack of awareness among general population, patients reaching hospital beyond window period, cost of treatment pose difficulty in administration of this treatment. This article presents demographic profile of patients undergoing IV thrombolysis for acute ischemic stroke at a hospital from Kutch, Gujarat. This article also highlights the importance of strong interpersonal communication between physician for better outcomes in patients. The aim of this observational study is to observe demographic profile of patients with acute ischemic stroke receiving intravenous thrombolysis and to estimate the factors which might help in favorable patient outcome. The data was calculated during January 2023 to December 2023. 22 patients were thrombolysed for acute ischemic stroke within 4.5 hours from onset of symptoms. Males were predominant (86.3%), average age of patients was 57.4 years (range 31 – 80 years old). Majority of the strokes were anterior circulation stroke (77.2%). The comorbidities like Diabetes mellitus (36.3%), hypertension (54.5%), dyslipidemia (59%), old coronary artery disease (18%), old cerebro vascular disease (4.5%) were seen. The time from symptom onset to presentation to hospital is approximately 146 minutes. The time from presentation to hospital and IV thrombolysis administration is approximately 49 minutes. 17(77.2%) patients presented to hospital within 3 hours of symptom onset, 13 (59%) underwent IV thrombolysis within 30 minutes of presentation to hospital. Majority of this patients were referred by primary physician to the hospital. Mild stroke (NIHSS < 5) was seen in 1 (4.5%) patient, moderate (NIHSS 5-15) in 11(50%) patients, moderate -severe stroke (NIHSS 15-25)– in 10(45.5%) patients. Large vessel occlusion was seen in 12 (54.5 %), small vessel disease in 4 (18 %), Embolic etiology in 4(18%) and unknown in 2 (9%) of cases. The mean NIHSS at presentation was approximately 16, at 24 hours after IV thrombolysis was approximately 11.3 and after 72 hours of IV thrombolysis is 8.6. Early neurological deficit was seen in 6(27.2%) of cases. 4(18%) of all stroke who underwent thrombolysis required decompression craniotomy. The improving on mRS (grade 0-1) score was found in 16(72.8%) patients at 7 days of thrombolysis. Intravenous thrombolysis with recombinant tissue plasminogen activator is helpful in acute ischemic stroke within 4.5 hours of onset. Early diagnosis and swift evaluation and management helps in prevention of longterm disability.

Intravenous thrombolysis in acute ischemic stroke: A prospective cross-sectional observational study in Kashmir

Experience of tenecteplase in acute ischemic stroke from Kutch, Gujarat; Strong interpersonal communication between doctors leads to favorable outcomes

[Factors Related to Therapeutic Outcomes of Intravenous Thrombolysis in Stroke Patients with Different Severity].

STUDY OF INTRAVENOUS THROMBOLYSIS IN ACUTE ISCHEMIC STROKE IN THE SOUTHERN PART OF INDIAAND ITS OUTCOME, A SINGLE CENTER STUDY

Safety and efficacy of intravenous thrombolysis in acute ischemic stroke patients with a history of intracranial hemorrhage: A systematic review and meta-analysis

Assessing mortality and safety of IV thrombolysis in ischemic stroke patients on direct oral anticoagulants (DOACs): A systematic review and meta-analysis

The effect of intravenous thrombolysis in stroke patients with unsuccessful thrombectomy

Abstract WP100: Trends in the Utilization of Intravenous Thrombolysis for Ischemic Stroke in Korea From 2013 to 2022

Use of Intravenous Thrombolytic Therapy in Acute Ischemic Stroke Patients: Evaluation of Clinical Outcomes

Intravenous thrombolysis in stroke with admission NIHSS score 0 or 1

Abstract WP31: Real World Comparison of Outcomes of IV Tenecteplase versus IV Alteplase for Acute Ischemic Stroke

[Thrombolysis alert in ischemic stroke: experience of the international private clinic Al Badie in Fez (cross-sectional study of 60 cases)]

Safety of Intravenous Thrombolysis in Chronic Intracranial Hemorrhage: A Five-Year Multicenter Study

Intravenous Thrombolysis in Patients With Cervical Artery Dissection: A Secondary Analysis of the STOP-CAD Study

Quality of Life After Intravenous Thrombolysis for Acute Ischemic Stroke: Results From the AcT Randomized Controlled Trial

Safety and efficacy of intravenous thrombolytic therapy in the extended window up to 24 hours: A systematic review and meta‐analysis

Outcome of intravenous thrombolysis in acute ischemic stroke patients with small vessel disease

Intravenous thrombolysis for treatment of pediatric acute ischemic stroke: Analysis of 20 years of population-level data in the United States

Abstract WP184: Intravenous Thrombolysis Improves Outcomes in Stroke Patients With Unsuccessful Mechanical Thrombectomy

Abstract WMP11: Intravenous Thrombolysis in Patients Without versus With Visible Occlusion: A Secondary Analysis From the AcT Trial

Abstract 25: Intravenous Thrombolysis for Acute Ischemic Stroke in Patients With Recent Direct Oral Anticoagulant Use: A Systematic Review and Meta-Analysis